Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

NCT01296243 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Tesetaxel

Sponsor

Genta Incorporated